Notes
incremental cost-effectiveness ratio
Reference
de Vries FM, et al. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands. Value in Health 17: 223-30, No. 2, Mar 2014. Available from: URL: http://doi.org/10.1016/j.jval.2013.12.010
Rights and permissions
About this article
Cite this article
When is it cost effective to treat diabetes patients with statins?. PharmacoEcon Outcomes News 700, 10 (2014). https://doi.org/10.1007/s40274-014-1177-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1177-4